Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Aditxt, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −5 vs. Q4 2025
- Shares held
- 20.3K
- −38.6K (−65.5%) vs. Q4 2025
- Total value
- $19.8K
- −$28.6K (−59.0%) vs. Q4 2025
- New holders
- 1
- 2 more added
- Sold out
- 6
- 2 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 9 | $19.8K |
| Q4 2025 | 14 | $48.4K |
| Q3 2025 | 14 | $35.9K |
| Q2 2025 | 13 | $50.5K |
| Q1 2025 | 9 | $213.3K |
| Q4 2024 | 11 | $13.9K |
| Q3 2024 | 13 | $29.7K |
| Q2 2024 | 8 | $23.4K |
| Q1 2024 | 10 | $62.2K |
| Q4 2023 | 11 | $31.2K |
| Q3 2023 | 12 | $826.4K |
| Q2 2023 | 14 | $313.8K |
| Q1 2023 | 15 | $618.3K |
| Q4 2022 | 16 | $805.6K |
| Q3 2022 | 16 | $983.2K |
| Q2 2022 | 28 | $392.5K |
| Q1 2022 | 23 | $1.14M |
| Q4 2021 | 27 | $2.01M |
| Q3 2021 | 25 | $2.48M |
| Q2 2021 | 18 | $1.62M |
| Q1 2021 | 22 | $1.63M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Aditxt, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 11,721 | $11.5K | 0.00% | +11,721 | New |
| Morgan Stanley | 8,002 | $7.83K | 0.00% | +8,001+800,100.0% | Added |
| Tower Research Capital LLC (TRC) | 547 | $535 | 0.00% | −390−41.6% | Reduced |
| Danske Bank A/S | 3 | $3 | 0.00% | +1+50.0% | Added |
| Group One Trading, L.P. | 2 | $2 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $1 | 0.00% | −621−99.8% | Reduced |
| IFP Advisors, Inc | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Darwin Advisors, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,079−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −15,904−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,844−100.0% | Sold out |
| Flow Traders U.S. LLC | 0 | $0 | 0.00% | −12,453−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |